| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |